PT-141

PT-141 (Bremelanotide): Compound Overview
What is PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide analog of α-melanocyte-stimulating hormone (α-MSH). Unlike other compounds that target the vascular system (such as PDE5 inhibitors), PT-141 acts on the central nervous system to influence sexual arousal. It has been widely studied in the context of hypoactive sexual desire disorder (HSDD), as well as for general libido enhancement in both male and female animal models.
Mechanism of Action
PT-141 primarily targets melanocortin receptors, particularly MC3R and MC4R, in the brain. This central action is believed to increase sexual desire and arousal by modulating dopamine-related pathways. Unlike sildenafil and similar compounds that act peripherally by increasing blood flow, PT-141 initiates arousal by stimulating neurological activity related to sexual behavior, which makes it particularly valuable in behavioral and neuroendocrine research.
Safety Profile
In research and early clinical studies, PT-141 has demonstrated good tolerability. Reported side effects in laboratory models include transient nausea, flushing, and occasional headache. Because it acts centrally, it does not appear to significantly affect blood pressure or cardiovascular function. However, it remains a research chemical and is not approved for unregulated or personal use outside of clinical trials.
Key Studies
Studies have shown PT-141’s ability to restore sexual function in animal models with sexual dysfunction or low libido, with consistent results in both male and female subjects.
Human trials in the early 2000s supported its application for treating HSDD and ED (erectile dysfunction), with further exploration into safe delivery methods.
Research has also evaluated its psychotropic and neuromodulatory potential, given its effects on mood and behavior in some animal studies.
Conclusion
PT-141 is a unique melanocortin receptor agonist that offers researchers a new avenue for studying the neurological and behavioral regulation of sexual function and desire. Its ability to directly activate central pathways involved in libido sets it apart from traditional vasodilatory treatments. PT-141 is for laboratory research use only and is not for human consumption.